Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist

Details for Australian Patent Application No. 2005206489 (hide)

Owner Schering Corporation

Inventors Thiruvengadam, Tiruvettipuram K.; Wu, Wenxue; Chackalamannil, Samuel; Chiu, John S.; Kosoglou, Teddy; Pavlovsky, Anastasia; Greenlee, William J.; Wang, Tao; Chintala, Madhu; Bogdanowich-Knipp, Susan; Graziano, Michael P.

Agent Griffith Hack

Pub. Number AU-B-2005206489

PCT Pub. Number WO2005/070923

Priority 10/755,066 09.01.04 US

Filing date 7 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 1 September 2011

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 521/00 (2006.01) Heterocyclic compounds containing unspecified hetero rings

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070923 Priority application(s): WO2005/070923

1 September 2011 Application Accepted

  Published as AU-B-2005206489

12 January 2012 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206497-Azadecalin glucocorticoid receptor modulators

2005206487-Processes for starting up an autothermal reformer